Kay Sung, M.D.
Dermatology Physician in Newport Beach, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 15,011 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Kay Sung, M.D. reported a CMS MIPS final score of 73.3/100 - below the 83.5 national average - and filed 242 Medicare Part D claims in 2024.
- 73.3/100
- MIPS score · -10 vs avg
- 242
- Part D claims, 2024
- 91%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Kay Sung, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1336278720), first enumerated 03/03/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 242 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 73.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Kay Sung, M.D.'s individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1336278720 · Dermatology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-LOW · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1336278720
- ENUM-MID 2007
- TAX-MID 15K Dermatology Physician
- MIPS-LOW 73.3/100
- RX-LIGHT 242
- BOOK-LIGHT 2,004 in California
- PHOTO-FINISH Robert Schwartz · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Sung · this prov…
Sung · this provider
73.3 MIPS pts
- Michael Centilli…
Michael Centilli, D.O.
73.3 MIPS pts
- Robert Schwartz …
Robert Schwartz
73.3 MIPS pts
- Lee Laris, DO · …
Lee Laris, DO
73.3 MIPS pts
- Nichelle Madden,…
Nichelle Madden, D.O.
73.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Kay Sung, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
73 ≥ 11th percentile 11% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Kay Sung, M.D. sits
This provider among dermatology physician peers
Across the 5,700 dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Kay Sung, M.D. writes more Part D claims than 16% of them and scores higher on MIPS quality than 16% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one dermatology physician peer from a representative sample of 60; the gold marker is Kay Sung, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Kay Sung, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kay Sung, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Dermatology Physician compares to other specialties among California providers
Dermatology Physician ranks #62 among California's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Dermatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Kay Sung, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 73.3/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Dermatology Physician US NPIs
73.3/100 MIPS final score - 10.2 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician. Quality dim: 46.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1336278720 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 03/03/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Kay Sung, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1336278720 is the unique 10-digit identifier CMS uses to link Sung across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Kay Sung, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Kay Sung, M.D.. To verify Kay Sung, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 242 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 259.5
- Total Day Supply
- 6,751
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $42K
- Generic Drug Cost
- $9K
- Antibiotic Claims
- 19
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 0.99
- Gender Split
- 41% female / 59% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Kay Sung, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Clobetasol Propion…
Clobetasol Propionate
37 claims
- Mometasone Furoate
Mometasone Furoate
36 claims
- Ketoconazole
Ketoconazole
35 claims
- Doxycycline Hyclate
Doxycycline Hyclate
17 claims
- Mupirocin
Mupirocin
17 claims
- Pimecrolimus
Pimecrolimus
15 claims
- Fluorouracil 13
Fluorouracil
13 claims
- Metronidazole 13
Metronidazole
13 claims
| Drug | Claims |
|---|---|
| Clobetasol Propionate | 37 |
| Mometasone Furoate | 36 |
| Ketoconazole | 35 |
| Doxycycline Hyclate | 17 |
| Mupirocin | 17 |
| Pimecrolimus | 15 |
| Fluorouracil | 13 |
| Metronidazole | 13 |
| Dupixent Pen Dupilumab | 11 |
| Valacyclovir Valacyclovir Hcl | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Kay Sung, M.D. fits within the Dermatology Physician landscape nationally.
Kay Sung, M.D.'s 242 claims are below the specialty average of 799.
Nationwide Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Sung, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (73.3 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Sung.
One of 2,004 Dermatology Physician providers enrolled in California, 5 are shown here.
Compare Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Kay Sung, M.D.'s specialty? ▼
How much does Kay Sung, M.D. prescribe under Medicare Part D? ▼
What is Kay Sung, M.D.'s Medicare quality score? ▼
Where is Kay Sung, M.D. located? ▼
What is Kay Sung, M.D.'s NPI number? ▼
Does Kay Sung, M.D. prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does Kay Sung, M.D. prescribe most often? ▼
Does Kay Sung, M.D. accept Medicare? ▼
How can I verify Kay Sung, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.